Navigation Links
Companion Diagnostics Market: Neurology & New Oncology Applications is Expected to Gain a Larger Share to 2019 Says a New Research Report Available at ReportsnReports.com
Date:9/9/2014

DALLAS, Sept. 9, 2014 /PRNewswire-iReach/ -- The global companion diagnostics market is expected to grow at a CAGR of 22.7% from 2014 to 2019. Factors such as rising need for personalized medicine in cancer treatment, growing adoption of companion diagnostics by the pharmaceutical industry, support from regulatory authorities, and emerging technologies such as next-generation sequencing (NGS) are expected to boost the global companion diagnostics market.

Photo - http://photos.prnewswire.com/prnh/20140909/144476

Among technologies, PCR is the most preferred test in the companion diagnostics market, which accounted for a share of 65.5% in 2014. This large share can be attributed to its ease of use, better results, faster turnaround time, and cost-effective solutions. The companion diagnostics market is expected to gain a larger market share in neurology and new oncology applications (leukemia, prostate cancer, and ovarian cancer) due to its efficient detection of biomarkers. Moreover, with the advancement in the bioinformatics field, NGS-based tests have the capability to target multiple genomes simultaneously and are likely to take over the existing technologies in the companion diagnostics market. The need for personalized medicine is increasing and it has gained importance in the research and medical centers, hospitals, and CROs. In the coming years, Asia is expected to be the key growth area in this market.

However, growth of this companion diagnostics market is hampered by the non-validated home brew tests that account for a large market share due to its low costs and minimal approval procedures. Moreover, uncertain reimbursement and coverage policies restrict the growth of the global companion diagnostic market, thus limiting the commercialization process.

Complete report is available at http://www.reportsnreports.com/reports/297416-companion-diagnostics-market-bytechnology-polymerase-chain-reaction-in-situ-hybridization-immunohistochemistry-application-breast-lung-cancer-by-end-user-pharmaceutical-companies-reference-lab-global-trends-forecasts-to-2019.html .

Reasons to Buy the Report

This companion diagnostics market report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of the top players in the companion diagnostics market. The report analyzes the companion diagnostics market by technology, application, end-user, and geography
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the companion diagnostics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographical and business segments, and product portfolios of the leading players in the companion diagnostics market
  • Market Development: Comprehensive information about the emerging markets. The report analyzes the market for various companion diagnostics tests/kits across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the companion diagnostics market

The major players in the global companion diagnostics market include Abbott Laboratories, Inc., Agilent Technologies, Inc., Biomérieux, Biogenex Laboratories, Danaher Corporation, Ge Healthcare, Myriad Genetics, Inc., Qiagen N.V., Roche Diagnostics, and Thermo Fisher Scientific, Inc. available for purchase at http://www.reportsnreports.com/Purchase.aspx?name=297416 .

Table of Contents for Companion Diagnostics Market by Technology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019 Research Report Cover:

1 Introduction

1.1 Objectives Of The Study

1.2 Markets Covered

1.3 Stakeholders

1.4 Market Scope

2 Research Methodology

2.1 Market Size Estimation

2.2 Market Share Estimation

3 Executive Summary

4 Premium Insights

5 Market Overview

5.1 Introduction

5.2 Evolution

5.3 Market Segmentation

5.4 Market Dynamics

6 Industry Trends

6.1 Porter's Five Forces Analysis

6.2 Strategic Benchmarking

7 Global Companion Diagnostics Market, By Applications

7.1 Introduction

7.2 Breast Cancer

7.3 Lung Cancer

7.4 Colorectal Cancer

7.5 Melanoma

7.6 Gastric Cancer

7.7 Other Indications (Prostate, Ovarian, Leukemia, Infectious Disease & Neurology)

8 Global Companion Diagnostics Market, By Technology

8.1 Introduction

8.2 Polymerase Chain Reaction (PCR)

8.3 In Situ Hybridization (ISH)

8.4 Immunohistochemistry (IHC)

8.5 Other Technologies (NGS,Multiplex Assay, Cellular Immune Testing, Mab)

9 Market, By End User

9.1 Introduction

9.2 Pharmaceutical Companies

9.3 Reference Lab

9.4 Others (Cro, Physicians, Hospitals & Academic Medical Centers)

10 Global Companion Diagnostics Market, By Geography

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia

10.5 Rest Of The W0rld

11 Competitive Landscape

11.1 Overview

11.2 Agreements, Partnerships & Collaborations

11.3 Merger And Acquisitions

11.4 New Product Launches

11.5 Expansion

12 Company Profiles

12.1 Introduction

12.2 Abbott Laboratories, Inc.

12.3 Agilent Technologies, Inc.

12.4 Biomérieux

12.5 Biogenex Laboratories

12.6 Danaher Corporation

12.7 Ge Healthcare

12.8 Myriad Genetics, Inc.

12.9 Qiagen N.V.

12.10 Roche Diagnostics

12.11 Thermo Fisher Scientific, Inc.

Priced at US$ 4650 for  a single user PDF license, request a discount on this research at http://www.reportsnreports.com/contacts/Discount.aspx?name=297416 .

About Us: 

ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. Our research specialists & industry experts, through our market research offerings, ensure we deliver on all your business & industry research requirements - first time and every time! (http://www.reportsnreports.com/ ).

Media Contact: Priyank Tiwari, ReportsnReports, +1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ReportsnReports
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
2. Companion Diagnostics and Personalized Medicine Market Report 2012: Twease.org
3. Life Technologies to Partner with Bristol-Myers Squibb for Companion Diagnostics Development
4. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
5. Eutropics Pharmaceuticals signs $1.5M NCI/SBIR contract to develop companion diagnostic for guiding Multiple Myeloma treatments
6. Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
7. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
8. The Complete Guide to Companion Diagnostics: Market Environment Products and Companies
9. Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
10. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
11. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... Careers in emergency medical ... southeast of Phoenix, Unitek EMT provides U.S. and international residents with an exceptional ... pursue their dream careers without spending years in school. Over the course of ...
(Date:7/13/2019)... Texas (PRWEB) , ... July 12, 2019 , ... ... million Americans’ ability to communicate and socialize with others. Given how widespread autism ... someone on the spectrum! While autism cannot be “cured,” there are treatment options ...
(Date:7/11/2019)... ... July 11, 2019 , ... AngelEye Health, ... MSN, RN, NEA-BC, as a clinical advisor. Jaylee will be focused on supporting ... team with more than a decade of progressive clinical experience, most recently serving ...
Breaking Medicine Technology:
(Date:7/13/2019)... ... July 14, 2019 , ... Dr. Rupa Jolly, dentist and ... New Orleans Advocate's A-List of Most Influential New Orleanians in 2019. She joins more ... other newsmakers that have made an impact on the New Orleans community. , Combining ...
(Date:7/13/2019)... ... July 12, 2019 , ... ... and CUBIO Innovation Center , sponsored by Hangzhou Investment Promotion Bureau, Fox ... June 2, 2019. , The conference attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, ...
(Date:7/11/2019)... ... July 11, 2019 , ... The ... resources with a range of features to further advance their mission of delivering ... in manufacturing quality medicines for patients worldwide. The latest additions include a new ...
(Date:7/10/2019)... ... July 10, 2019 , ... ... treatment, Shady Grove Fertility (SGF) remains committed to its core mission ... Throughout the month of July, the practice will host six in-person seminars and ...
(Date:7/9/2019)... ... July 09, 2019 , ... Leading healthcare digital transformation platform ... Cancer Institutes – Clinical Research Innovation (AACI-CRI) annual meeting, held in Chicago, to ... analysis. As the leading provider of clinical research technology solutions, Forte continues to ...
Breaking Medicine News(10 mins):